multiple dose bioequivalence study [Design Issues]

posted by Loky do – Egypt, 2020-08-09 13:50 (1327 d 08:32 ago) – Posting: # 21842
Views: 2,664

Dears

If we have solifenacin 6 mg (immediate-release) / tamsulosin 0.4 mg modified-release product combination, is multiple-dose bioequivalence study required to be submitted to the European authorities in addition to fast & fed studies, as there is no specific guidance for this product & in GCC region fast & fed studies only accepted.

Thanks in advance

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
73 visitors (0 registered, 73 guests [including 9 identified bots]).
Forum time: 21:23 CET (Europe/Vienna)

Nothing shows a lack of mathematical education more
than an overly precise calculation.    Carl Friedrich Gauß

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5